Health Condition 1: B081- Molluscum contagiosum
Conditions
Interventions
Intervention1: injection MMR vaccine in molluscum contagiosum: Injection MMR 0.2ml will be injected into the largest lesion. The injections will be administered at 2-week intervals until complete clea
Sponsors
All Institute of Medical Sciences Bathinda
Eligibility
Inclusion criteria
Inclusion criteria: All consecutive untreated patients of molluscum contagiosum 2. Patients above 18 years of age 3. MC lesions more than 5
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating females. 2. Any evidence of immunosuppression, including HIV or family history of severe immune dysfunction. 3. With a prior history of hypersensitivity to Injection MMR 4. Patients having any significant systemic illness/ severe organ dysfunction or any sign of local infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients showing complete clearance of molluscum contagiosum lesions at 12 weeks follow up.Timepoint: Proportion of patients showing complete clearance of molluscum contagiosum lesions at 12 weeks follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| patients’ global assessment perceptions scoring at the end of treatment and at 24 weeks Score 1: Very much improved Score 2: Much improved Score 3: Minimally improved Score 4: No improvement Score 5: Minimal worse Score 6: Much worse Score 7: very much worse 2. The patient will be evaluated for any adverse effects and will be documentedTimepoint: Baseline, 2weeks, 4 weeks, 6 weeks, 8 weeks,12 weeks(4 weeks after last injection), 24 weeks(12 weeks after last injection) | — |
Countries
India
Contacts
Public ContactKavita Poonia
AIIMS BATHINDA
Outcome results
None listed